ABSTRACT
INTRODUCTION
Helicobacter pylori infection colonizes the stomach of more than half of the world's population, and it has been believed to play a decisive role in such gastroduodenal diseases as chronic active gastritis, peptic ulcer, and gastric carcinoma and primary gastric lymphoma, especially the lymphoma of mucosa-associated lymphoid tissue (MALT) type. [1] [2] [3] In 1994 the International Agency for Research on Cancer World Health Organization classified H. pylori as group 1 recognized human carcinogen. 4 Studies have also reported that low grade gastric MALT lymphoma and gastric cancer may regress after the eradication of H. pylori. Several studies have demonstrated a reduction of the risk of gastric cancer after H. pylori eradication. [5] [6] [7] Infection with H. pylori is implicated in the pathogenesis and treatment of gastric MALT lymphoma, but the role of H. pylori in gastric Diffuse Large B-Cell Lymphoma (DLBCL) is uncertain . [8] [9] Gastric cancer is the fourth most common type of cancer and the second most common cause of cancer-related mortality around the world. 10 Lauren described the two histological types of gastric cancer as the intestinal and the diffuse types. 11 After the initiation by H. pylori and the influence of variable environmental and host factors, chronic active gastritis may progressively evolve to atrophic gastritis and intestinal metaplasia. In some individuals the metaplastic epithelium will undergo further genomic and phenotypic changes, resulting in gastric dysplasia and finally ending in adenocarcinoma.
12
In the current study, we investigated 255 patients with primary gastric lymphoma and gastric carcinoma to detect the prognostic role of H. pylori. The aim of this study was to determine the pattern of histologically-proven gastric cancer and lymphoma and explore its association with H. pylori infection.
METHODS
For the purposes of this study, the medical records of the patients treated at five Medical Centers in Turkey between 2005 and 2010 were retrospectively evaluated. The inclusion criteria were a histologically confirmed adenocarcinoma of the stomach or primary gastric lymphoma. Approving for this study was taken by the ethics committee. We obtained written informed consent from all participants, H. pylori status was performed by histological in the surgical specimens. Hematoxylin and eosin stain was used to evaluate the presence or absence of H. pylori on formalin fixed, paraffin embedded specimens. 13 We defined a positive result for H. pylori infection as when the histological result was positive. Pathologic results were recorded, including the tumor size, location, and type, according to the Lauren and WHO histological classifications. A histologic classification of the primary gastric lymphoma specimens was performed according to the criteria of Isaacson et al. 14 Disease stage was designated in all patients according to the Lugano staging system for gastrointestinal non-Hodgkin's lymphoma. 15 Disease stage was performed according to the guidelines of the American Joint Committee on Cancer (AJCC) (6 th and 7 th edition) for gastric cancer. 16 All patients in this study were assessed for the recurrence of gastric cancer and death every three to six months through the use of computed tomography, tumor marker expression and physical examination. A chi-squared test was used to analyze correlations between the clinicopathologic features and H. pylori status. Overall and disease-free survival and H. pylori status were analysed using the Kaplan-Meier test. Statistical analyses were performed using SPSS 18.0 for Windows, and p values <0.05 were considered statistically significant.
RESULTS
A total of 115 cases of gastric cancer and 140 cases of primary gastric lymphoma were diagnosed. The median age of the all patients was 58 years (range=18-85 years). There were 152 males (59.6%) and 103 females (40.4%) with a male to female ratio of 1.4-1. Characteristics of the all patients are summarized in Table 1 . According to the AJCC staging system of the patients of gastric cancer (n=105), 67 (63.8%) were at stage I-II, while 28 (36.2%) were at stage III-IV. According to the Lauren classification, 47 (58.0%) patients had the intestinal type of gastric cancer and 34 (42.0%) had the diffuse type. In the examining of 115 patients with gastric cancer in term of H. pylori infection, 62 (53.9%) of the patients were positive and 53 (46.1%) of the patients were negative (p<0.001) ( (Figure 1 ). The overall frequency of H. pylori infection in primary gastric lymphoma cases was 23% (34/140). The frequency of H. pylori positivity was differ between MALT lymphomas (53.5%) and lymphomas other than DLBCL (18.7%) (p<0.001). The proximal stomach (corpus and fundus) was the most commonly involved area within the stomach site (66 cases, 61%) in our study, followed by the distal stomach (antrum, pylor) (41 cases, 39% Figure 2) ; however, the 3-year and 5-year DFS rates were 82.4% and 82.4% for the H. pylori-positive with primary gastric lymphoma cases, whereas they were 78.0% and 71.5% for the H. pylori-negative cases, respectively (p=0.833) ( Table  2 ). For patients with primary gastric lymphoma, H. pylori status did not correlate with the DFS and OS. 
DISCUSSION
Helicobacter pylori infection remains common worldwide and is significantly associated with gastric adenocarcinoma and gastric MALT lymphoma. 17 Between gastric cancer and primary gastric lymphoma were significant differences in terms of the presence of H. pylori. There was a higher rate of H. Epidemiological studies have demonstrated a significant correlation between H. pylori infection and gastric cancer, indicating that H. pylori infection may be involved in approximately 35-60% of gastric cancer cases. 1, 19 In our study, H. pylori positivity was significantly lower than in other studies that used serologic test. It may be due to no serologic tests were available in our study. Some recent studies have described the regression of low grade gastric MALT lymphoma after the eradication of H. pylori. 20, 21 In our region, the high rate H. pylori positivity (57.1%) in stomach cancer was also seen in previous studies. 22 For this reason, H. pylori eradication may be the strategy in the patients with gastric cancer. The strategy of test, treat and screening for H. pylori infection is effective in reducing the incidence and mortality of gastric cancer in communities with a high incidence of gastric cancer. The risk of non-cardia gastric cancer was about six times higher in those who tested positive for H. pylori. H. pylori infection was detected more frequently in the intestinal type of tumor and distal gastric cancer. In the study conducted on a Turkish population, positive H. pylori tests were more common in patients with distal gastric cancer and intestinal type of tumor; and the difference was found as statistically significant. 23 Epidemiological studies suggest a strong association between H. pylori infection and distal gastric cancer. One estimate attributed 70% of non-cardiac gastric adenocarcinoma to H. pylori infection. 24 Overall 5-year survival between 50% and 70% is reported with multimodality therapy for gastric lymphoma. 25 The prognosis of gastric cancer continues to be poor, with a 5-year survival rate of approximately 20% except for a few countries (e.g. 40%-60% in Japan). 26 In this study, survival rates were similar in the cases of gastric cancer and lymphoma. The most important prognostic factor for gastric cancer and lymphoma patients is tumor-node-metastasis (TNM) stage. The prognostic significance of H. pylori, which is an important predisposing factor in the pathogenesis of gastric malignancies, have evaluated in very few studies. In performed a study, a negative H. pylori status may be a predictive factor for recurrence in patients diagnosed with advanced gastric adenocarcinoma. 27 In other study, negative H. pylori status appears to be an indicator of poor prognosis in patients with gastric cancer, and is independent of other well-known clinical and pathologic prognostic variables. 28 H pylori was an independent prognostic factor for DFS and OS. H. pylori positive patients had a significantly better survival. 29 In conclusion, H. pylori status did not correlate with the clinicopathologic factors of gastric adenocarcinoma and primary gastric lymphoma in our study. There was no correlation between H. pylori status and stage in this study.
